← All organizations

Cardior Pharmaceuticals GmbH

For profitWebsite ↗

Also known as: Cardior Pharmaceuticals GmbH | Cardior Pharmaceuticals GmbH CMO

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2023

Acquired by Novo Nordisk on Mar 25, 2024

Timeline

2010s

Jan 1, 2016
Cardior Pharmaceuticals GmbH— Founded

2020s

Mar 25, 2024
Novo Nordisk— Acquired By

Drugs by trial phase (1 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

cdr132l

Indications

Studied for

Heart Failure

Recent trials (4)

NCT05953831Lead sponsorPhase 2Dec 31, 2023
NCT05350969Lead sponsorPhase 2Jun 27, 2022
NCT04045405Study directorPhase 1Jun 21, 2019
NCT04045405Lead sponsorPhase 1Jun 21, 2019

Details

Founded: Hannover, DE Jan 1, 2016
Last known activity: Dec 31, 2023